NCT01610531

COPARIME: Pilot Study of a Target Detection of Malignant Melanoma

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 4,118 (actual)
• Sponsor: Nantes University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Melanoma is nowadays an important public health problem because its growing incidence. Mass screening for melanoma is not recommended worldwide because of its low cost-effectiveness. Nevertheless targeted screening for patients at high risk for melanoma is promoted. This study is designed to assess the effectiveness and the acceptability of a melanoma targeted screening of melanoma, to estimate the risk function to develop a melanoma among patients at high risk according to the SAMScore and to estimate the ratio cost/ efficacy of the melanoma targeted screening. A cohort of 7700 patients is carried out in 2 departments covered by a registry of cancers. The recruitment had began in April 2011. Patients assessed at high risk according to the SAMScore were proposed a skin examination by their GP every year.

Conditions

• Patients at Risk for Melanoma

Interventions

Type	Name	Description
OTHER	SAMScore questionnaire	Patients assessed at high risk according to the SAMScore

Timeline

• Start date: 2011-04-01
• Primary completion: 2018-02-01
• Completion: 2018-02-01
• First posted: 2012-06-04
• Last updated: 2018-07-27

Locations

1 site across 1 country: France